invaio sciences, based in Cambridge, MA, is a transformative early-stage startup developing a multi-industry platform that will bring to market novel, specific and natural products to precisely control and modulate invertebrate health. Our enthusiasm, ambition, passion and creativity, coupled with our unique blend of innovation, science and business focus, creates an exciting entrepreneurial environment.
invaio sciences, is one of the newest companies started by Flagship Pioneering, an early-stage life sciences innovation company. Since Flagship’s founding in 2000, the firm has originated and fostered the development of more than 75 scientific ventures resulting in $20 billion in aggregate value, 500+ issued patents, and more than 50 clinical trials for novel therapeutic agents. “Innovation is our currency. Our creativity, optimism, boundless energy, and curiosity fuel Flagship’s success.”